Since VAP-1 is indicated in playing a role also in other physiological and pathological processes, presumably through the SSAO-activity, the effect VAP-1Δ3 exerts on the functional properties of full-length VAP-1 might have consequences also on other disease entities, like atherosclerosis and diabetes [12], [13]. This evidence concerns the gene AOC3 and diabetes mellitus.